BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3811070)

  • 1. [Diagnostic significance of determining 3-hydroxyanthranilic acid in patients with precancerous diseases and cancer of the bladder].
    Klimenko IA; Romanenko AM; Korosteleva TA; Belokhvostova AT
    Urol Nefrol (Mosk); 1986; (6):30-4. PubMed ID: 3811070
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antigen, containing tryptophan metabolite, 3-oxyanthranilic acid, in blood serum of patients with stomach neoplasms].
    Korosteleva TA; Mel'nikov RA; Belokhvostova AT
    Vopr Onkol; 1976; 22(10):22-6. PubMed ID: 1014489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunodiagnosis of precancerous changes in the urinary bladder of workers in the the textile industry].
    Korosteleva TA; Kliucharev BK; Belokhvostova AT; Syromiatnikov AA
    Vopr Onkol; 1973; 19(2):28-32. PubMed ID: 4763782
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of hydroxyanthranilic acid in the blood serum for the immunodiagnosis of tumors of the urinary bladder].
    Korosteleva TA; Kliucharev BV; Belokhvostova AT; Syromiatnikov AA; Benteleva TA
    Biull Eksp Biol Med; 1974 Aug; 78(8):80-2. PubMed ID: 4433767
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of 3-oxyanthranilic acid in the blood serum in the immunodiagnosis of precancerous changes in the mucous membrane of the urinary bladder].
    Korosteleva TA; Kliucharev BV; Belokhvostova AT; Syromiatnikov AA; Benteleva TA
    Biull Eksp Biol Med; 1974 Dec; 78(12):65-7. PubMed ID: 4216380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic determination of 3-hydroxyanthranilic acid in the blood of patients with tumors of the large intestine and rectum].
    Korosteleva TA; Mel'nikov RA; Belokhvostova AT
    Vopr Onkol; 1976; 22(5):28-32. PubMed ID: 936541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3-Hydroxyanthranilic acid in the blood of patients with kidney tumors].
    Korosteleva TA; Kliucharev BV; Belokhvostova AT
    Vopr Onkol; 1976; 22(11):95-8. PubMed ID: 1014510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The excretion of 3-hydroxyanthranilic acid in patients with bladder and kidney carcinoma.
    Teulings FA; Mulder-Kooy GE; Peters HA; Fokkens W; Van Der Werf-Messing B
    Acta Vitaminol Enzymol; 1975; 29(1-6):108-12. PubMed ID: 1244078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An immunologic method of detecting 3-hydroxyanthranilic acid in the serum of patients with urinary bladder cancer].
    Korosteleva TA; Kliucharev BV; Belokhvostova AT
    Vopr Onkol; 1971; 17(3):59-63. PubMed ID: 4998157
    [No Abstract]   [Full Text] [Related]  

  • 10. [3-hydroxyanthranilic acid content in the urine of bladder cancer patients].
    Korosteleva TA; Kliucharev BV; Benteleva TA
    Vopr Onkol; 1979; 25(6):36-9. PubMed ID: 462869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of lyophilized blood serum for determining the 3-HAA antigen in patients with precancerous diseases and cancer of the bladder].
    Klimenko IA; Sakalo VS; Korosteleva TA; Belokhvostova AT; Sakalo AV
    Lik Sprava; 1992; (11-12):49-52. PubMed ID: 1292221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of 3-hydroxyanthranilic acid-antigen on the migration of peripheral blood leukocytes in patients with bladder tumors].
    Korosteleva TA; Kliucharev BV; Skadova VM; Vorob'ev AV; Chebotkevich VN
    Vopr Onkol; 1987; 33(5):59-62. PubMed ID: 3296440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical diagnosis of pretumorous diseases of the bladder].
    Klimenko IA
    Urol Nefrol (Mosk); 1985; (2):33-7. PubMed ID: 3992754
    [No Abstract]   [Full Text] [Related]  

  • 14. [3-HAA-antigen and immunoreactivity indices in patients with bladder tumors].
    Korosteleva TA; Rabkova LM; Belokhvostova AT; Movsesian KS; Skadova VM
    Vopr Onkol; 1986; 32(9):48-53. PubMed ID: 3765523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperplastic-proliferative and preneoplastic lesions of the bladder urothelium (author's transl)].
    Mattarozzi A; Zaniboni P; Zanella L; Bacchini P; Bertoni F
    Pathologica; 1981; 73(1026):597-612. PubMed ID: 7312433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological reaction to 3-hydroxyanthranilic acid in the diagnosis of lung cancer].
    Kolesnikov IS; Lytkin MI; Korosteleva TA; Shalaev SA; Belokhvostova AT
    Vestn Khir Im I I Grek; 1981 Apr; 126(4):3-7. PubMed ID: 6791347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urothelial lesions associated with bladder carcinoma. Histological study of 18 radical cystectomy specimens].
    Carrillo G; Nappi O; Iacobelli P
    Pathologica; 1981; 73(1026):589-96. PubMed ID: 7312432
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proceedings: Endogenous carcinogens. Experimental induction of malignant tumors and leukemias by the tryptophan metabolites 3-hydroxyanthranilic acid and 3-hydroxykynurenine].
    Ehrhart H
    Z Klin Chem Klin Biochem; 1972 Apr; 10(4):178-9. PubMed ID: 4681017
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on "Recognition of 'Early' Bladder Cancer and Premalignant Epithelial Changes".
    Veenema RJ
    Cancer Res; 1977 Aug; 37(8 Pt 2):2836. PubMed ID: 872110
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of cytodiagnosis in early detection of pre-malignant and malignant changes in the epithelium of the lower urinary tract].
    Breinl H; Dehnhard F
    Osterr Z Erforsch Bekampf Krebskr; 1971; 26(4):264-75. PubMed ID: 5171547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.